(OWL) Blue Owl Capital - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 14.702m USD | Total Return: -39.7% in 12m
Industry Rotation: -2.1
Avg Turnover: 259M
EPS Trend: 97.1%
Qual. Beats: 0
Rev. Trend: 99.6%
Qual. Beats: 0
Warnings
P/E ratio 78.6
Below Avwap Earnings
Tailwinds
No distinct edge detected
Blue Owl Capital Inc. (NYSE: OWL) is a New York-based alternative asset manager specializing in permanent capital solutions for middle-market companies, large-scale asset managers, and corporate real estate owners. The firm’s business model is organized into three primary pillars: Credit, GP Strategic Capital, and Real Estate. Its credit division focuses on direct lending and opportunistic financing, while the GP strategic capital segment provides minority equity and debt financing to other private equity firms.
The company’s real estate operations center on triple-net lease structures, where tenants are responsible for property taxes, insurance, and maintenance costs in addition to rent. Unlike traditional private equity firms that rely on periodic fundraising cycles, Blue Owl emphasizes a permanent capital base, which provides a stable fee-generating structure and reduces the pressure of immediate capital redemption. Investors may find it useful to examine ValueRay for deeper insights into the firms valuation metrics.
Operating within the Asset Management & Custody Banks sub-industry, Blue Owl leverages long-dated private funds to execute its investment strategies. This model allows the firm to provide holistic financing solutions, ranging from technology-specific lending to professional sports minority stakes, while maintaining a focus on investment-grade or creditworthy counterparties.
- Direct lending growth drives management fee revenue from middle market financing
- Permanent capital structure reduces redemption risk and stabilizes long-term earnings
- Strategic GP stakes expansion increases high-margin fee related earnings and carry
- Interest rate volatility impacts borrowing costs and private credit deployment spreads
- Real estate sale-leaseback demand fluctuates with corporate credit and macro conditions
| Net Income: 86.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 3.02 > 1.0 |
| NWC/Revenue: 14.50% < 20% (prev 14.26%; Δ 0.24% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.34b > Net Income 86.9m |
| Net Debt (4.17b) to EBITDA (967.0m): 4.31 < 3 |
| Current Ratio: 1.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (681.1m) vs 12m ago 6.67% < -2% |
| Gross Margin: 64.44% > 18% (prev 0.55%; Δ 6.39k% > 0.5%) |
| Asset Turnover: 23.81% > 50% (prev 20.07%; Δ 3.74% > 0%) |
| Interest Coverage Ratio: 3.45 > 6 (EBITDA TTM 967.0m / Interest Expense TTM 169.1m) |
| A: 0.03 (Total Current Assets 896.6m - Total Current Liabilities 470.3m) / Total Assets 12.41b |
| B: -0.14 (Retained Earnings -1.74b / Total Assets 12.41b) |
| C: 0.05 (EBIT TTM 583.6m / Avg Total Assets 12.35b) |
| D: -0.26 (Book Value of Equity -1.74b / Total Liabilities 6.63b) |
| Altman-Z'' Score: -0.19 = B |
| DSRI: 0.85 (Receivables 706.2m/692.8m, Revenue 2.94b/2.47b) |
| GMI: 0.85 (GM 64.44% / 54.63%) |
| AQI: 0.98 (AQ_t 0.87 / AQ_t-1 0.89) |
| SGI: 1.19 (Revenue 2.94b / 2.47b) |
| TATA: -0.10 (NI 86.9m - CFO 1.34b) / TA 12.41b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
Over the past week, the price has changed by +3.98%, over one month by +5.78%, over three months by +0.00% and over the past year by -39.73%.
- StrongBuy: 8
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.9 | 26.8% |
P/E Forward = 9.6712
P/S = 4.9998
P/B = 3.0352
P/EG = 0.137
Revenue TTM = 2.94b USD
EBIT TTM = 583.6m USD
EBITDA TTM = 967.0m USD
Long Term Debt = 3.83b USD (from longTermDebt, last quarter)
Short Term Debt = 530.7m USD (from shortTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.17b USD (from netDebt column, last quarter)
Enterprise Value = 18.87b USD (14.70b + Debt 4.36b - CCE 190.5m)
Interest Coverage Ratio = 3.45 (Ebit TTM 583.6m / Interest Expense TTM 169.1m)
EV/FCF = 14.71x (Enterprise Value 18.87b / FCF TTM 1.28b)
FCF Yield = 6.80% (FCF TTM 1.28b / Enterprise Value 18.87b)
FCF Margin = 43.63% (FCF TTM 1.28b / Revenue TTM 2.94b)
Net Margin = 2.96% (Net Income TTM 86.9m / Revenue TTM 2.94b)
Gross Margin = 64.44% ((Revenue TTM 2.94b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 87.94% (prev 62.00%)
Tobins Q-Ratio = 1.52 (Enterprise Value 18.87b / Total Assets 12.41b)
Interest Expense / Debt = 1.01% (Interest Expense 43.9m / Debt 4.36b)
Taxrate = 16.95% (16.2m / 95.8m)
NOPAT = 484.7m (EBIT 583.6m * (1 - 16.95%))
Current Ratio = 1.91 (Total Current Assets 896.6m / Total Current Liabilities 470.3m)
Debt / Equity = 2.07 (Debt 4.36b / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = 4.31 (Net Debt 4.17b / EBITDA 967.0m)
Debt / FCF = 3.25 (Net Debt 4.17b / FCF TTM 1.28b)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.70% (Net Income 86.9m / Total Assets 12.41b)
RoE = 3.89% (Net Income TTM 86.9m / Total Stockholder Equity 2.24b)
RoCE = 9.62% (EBIT 583.6m / Capital Employed (Equity 2.24b + L.T.Debt 3.83b))
RoIC = 8.59% (NOPAT 484.7m / Invested Capital 5.64b)
WACC = 10.00% (E(14.70b)/V(19.06b) * Re(12.71%) + D(4.36b)/V(19.06b) * Rd(1.01%) * (1-Tc(0.17)))
Discount Rate = 12.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 15.94%
[DCF] Terminal Value 75.36% ; FCFF base≈1.13b ; Y1≈1.39b ; Y5≈2.38b
[DCF] Fair Price = 36.51 (EV 28.84b - Net Debt 4.17b = Equity 24.67b / Shares 675.8m; r=10.00% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 97.13 | EPS CAGR: 14.01% | SUE: 0.94 | # QB: 0
Revenue Correlation: 99.56 | Revenue CAGR: 27.93% | SUE: 0.99 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.22 | Chg30d=-2.39% | Revisions=-27% | Analysts=13
EPS next Quarter (2026-09-30): EPS=0.23 | Chg30d=-3.39% | Revisions=-45% | Analysts=13
EPS current Year (2026-12-31): EPS=0.89 | Chg30d=-0.77% | Revisions=-20% | GrowthEPS=+5.5% | GrowthRev=+9.2%
EPS next Year (2027-12-31): EPS=0.99 | Chg30d=-4.53% | Revisions=-62% | GrowthEPS=+11.2% | GrowthRev=+11.4%
[Analyst] Revisions Ratio: -62%